Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation.

MLA

Wang, Judy, et al. “Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation.” Oncologist, vol. 27, no. 7, July 2022, p. 536. EBSCOhost, https://doi.org/10.1093/oncolo/oyab080.

APA

Wang, J., Martin-Romano, P., Cassier, P., Johnson, M., Haura, E., Lenox, L., Guo, Y., Bandyopadhyay, N., Russell, M., Shearin, E., Lauring, J., & Dahan, L. (2022). Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation. Oncologist, 27(7), 536. https://doi.org/10.1093/oncolo/oyab080

Chicago

Wang, Judy, Patricia Martin-Romano, Philippe Cassier, Melissa Johnson, Eric Haura, Laurie Lenox, Yue Guo, et al. 2022. “Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation.” Oncologist 27 (7): 536. doi:10.1093/oncolo/oyab080.